NCT04484688Unknown不适用
Perindopril+Bisoprolol in Therapy of Patients With Atrial Fibrilation
适应症
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- 12-ecg and echocardiography evaluation after 1 month treatment
研究概览
简要总结
The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •permanent atrial fibrillation with normal EF -
排除标准
- •AF with decreased EF
结局指标
主要结局
12-ecg and echocardiography evaluation after 1 month treatment
时间窗: 1 month
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/AmlodipineHypertensionNCT03738761KRKA471
已完成
3 期
Perindopril Amlodipine for the Treatment of HypertensionEssential HypertensionNCT01556997Symplmed Pharmaceuticals LLC837
已完成
4 期
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in KoreaHeart Failure, CongestiveNCT01074307Merck KGaA, Darmstadt, Germany180
已完成
4 期
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With DiabetesHypertensionNCT01190436Merck KGaA, Darmstadt, Germany125
尚未招募
1 期
A study combining blood pressure medication with standard treatment in advanced melanoma. ACE-IT-001Melanoma - UnresectableMelanoma - MetastaticCancer - Malignant melanomaACTRN12621000156886Calvary Mater Newcastle30